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Abstract
Background:  Transmission of hepatitis C vims (HCV) is strongly associated with use of
contaminated blood products and injection drugs. Other "non-parental" modes of transmission
including sexual activity have been increasingly recognized. We examined risk factors for acquiring
HCV in patients who were referred to two tertiary care centers and enrolled in an antiviral therapy
protocol.
Methods:  Interviews of 148 patients were conducted apart from their physician evaluation using
a structured questionnaire covering demographics and risk factors for HCV acquisition.
Results:  Risk factors (blood products, injection/intranasal drugs, razor blades/ toothbrushes,
body/ear piercing, occupational exposure, sexual activity) were identified in 141 (95.3%) of
participants; 23 (15.5%) had one (most frequently blood or drug exposure), 41 (27.7%) had two,
and 84 (53.4%) had more than two risk factors. No patient reported sexual activity as a sole risk
factor. Body piercing accounted for a high number of exposures in women. Men were more likely
to have exposure to street drugs but less exposure to blood products than women. Blood product
exposure was less common in younger than older HCV patients.
Conclusion:  One and often multiple risk factors could be identified in nearly all HCV-infected
patients seen in a referral practice. None named sexual transmission as the sole risk factor. The
development of a more complete profile of factors contributing to transmission of HCV infection
may assist in clinical and preventive efforts. The recognition of the potential presence of multiple
risk factors may have important implications in the approach to HCV surveillance, and particularly
the use of hierarchical algorithms in the study of risk factors.
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Background
An estimated 4 million individuals in the United States
and 200 million people worldwide are infected with the
hepatitis C virus (HCV) [1,2]. Infection with HCV may
lead to disabling symptoms, cirrhosis and hepatocellular
carcinoma [3,4] and is said to account for a significant
proportion of end-stage liver disease among HCV-infect-
ed individuals (incidence of 3.1 per 1000 person-years)
[5]. From 2010–2019, HCV may lead to the loss of 1.83
million years of life among those under 65, at a societal
cost of billions of dollars [6].
Blood-borne transmission of HCV infection is undisput-
ed and reflected in the prevalence of HCV among injec-
tion drug users (IDUs) and patients exposed to
contaminated blood products. HCV infection has also
been linked to other exposures such as intranasal co-
caine use ("snorting") [7], which probably promotes pas-
sage through vessels of the nasal septum. Centers for
Disease Control and Prevention (CDC) data have high-
lighted sexual exposure without other risk factors in 15–
20% patients; two-thirds had an anti-HCV positive sexu-
al partner [1,8], but sexual practices appear to play a mi-
nor role among IDUs [9,10,11,12]. For a perspective on
tertiary care settings we inquired about the routes of in-
fection in referred patients. We aimed to examine the
distribution of risk factors for HCV acquisition among
patients chronically infected with HCV who were seeking
anti-viral treatment in a tertiary care setting.
Methods
We recruited consecutive chronically infected HCV pa-
tients eligible for a trial of interferon-alpha and ribavirin
therapy at two academic referral settings. They were se-
lected from over 2500 patients referred to the University
of Alabama at Birmingham Liver Center and the Univer-
sity of South Alabama Gastroenterology and Hepatology
Division. Concomitant HBV or HIV infection or ad-
vanced liver disease (decompensated cirrhosis) were tri-
al exclusion criteria. Extensive data on demographic
factors as well as routes and estimated year of exposure
to known HCV risk factors were gathered in an inter-
viewer-assisted questionnaire (Table 1.A). Sexual expo-
sure, in the present study, was defined as having at least
1 sexual contact with an individual known or suspected
to have HCV. One investigator (LJY) conducted all inter-
views privately with assurance that data would remain
separate from medical records. To enhance recall, ques-
tions were repeated with different phrasing. Standard
statistical methods including calculations of prevalence,
mean, median and standard deviation were applied us-
ing SAS® software (Cary, NC). This study was approved
by the Institutional Review Board for Human Use of the
University of Alabama at Birmingham and patients gave
informed consent for the interviews.
Results
Demographics
Patient age ranged from 18 to 72 years with the mean ±
SD of 45 ± 8.1 years and a median age of 44 years. Of 148
patients, 88 (59.5%) were males; 130 (88%) were Cauca-
sians and 18 (12%) were African-Americans; 126 (85%)
had completed high school.
Table 1A: Number of known risk factors in 148 patients with chronic hepatitis C infection evaluated at two Alabama tertiary care med-
ical centers. A. Number and % of patients exposed to each risk factor (includes multiple exposures)*
KNOWN RISK FACTOR N (%) REFERENCES
No known risk factor 7 (4.7) —
Injection Drug or intranasal cocaine use 71 (48) 7
Sharing of razors and toothbrushes 65 (44) 17,18
Body/ear piercing 63 (42.6) 7,17
Recipient of blood (products) before 1992 62 (41.9) 7, 19, 20
Sexual exposure 55 (37.2) 1,8
Occupational exposure to blood 47 (31.8) 21
Tattooing 25 (16.9) 17,22,23
Hemodialysis 0 (0) 24,21
Acupuncture 0 (0) 25,26
*For example, if an individual has exposure to both blood products and tattooing, they are counted under "Tattooing" as well as "Recipient of blood 
(products) before 1992"
BMC Infectious Diseases (2001) 1:8 http://www.biomedcentral.com/1471-2334/1/8
Frequency of risk factors
Most patients (80%) reported more than one potential
exposure to HCV (Table 1.A.). Only 7 individuals (4.7%)
reported no risk factor (Table 1.B.). Injection drug use
was strongly associated with cocaine use (over 90% of in-
dividuals had both) and therefore they were combined in
the analysis. Among those who did not report concomi-
tant cocaine and injection drug use, the majority report-
ed only using injection drugs and as a result of these
small numbers, an analysis of cocaine as a sole risk factor
was precluded. Of the 23 persons with one risk factor, 10
(43.5%) had received a transfusion, 7 (30.4%) used intra-
venous drugs or cocaine; 3 (13.0%) underwent body/ear
piercing, 2 (8.7%) shared razors and toothbrushes, and
1(4.3%) had occupational exposure (needle stick, and ex-
posures to major amounts of blood, as from work in an
emergency room or administering first aid at a construc-
tion site). In no case was sexual activity reported as an in-
dependent risk factor.
Risk Factors and demographic characteristics
Patients exposed to blood products tended to be older
while IDUs and patients with sexual exposure or tattoos
tended to be younger (Table 32). Women reported more
risk factors than men. Exposure to blood products was
considerably more common in women than men and ex-
posure to intravenous drugs and intranasal cocaine more
common in men than women. Neither race nor educa-
tion was associated with the number of risk factors.
Prevalence of sexual exposure in conjunction with other 
risk factors
Sexual exposure was reported by 14 of 54 (25.9%) pa-
tients who had been tattooed, 33 of 53 (62.3%) who
shared razors/tooth brushes, and 16 of 34 (47.1%) who
received blood/blood products.
Discussion
Numerous risk factors promote HCV acquisition, and
multiple risk factors may be present in a single individu-
al. Infected persons cannot be dichotomized into "injec-
tion drug users" and "blood product recipients;" many in
each group may have other risk factors as well. Investiga-
tors pursuing research on the origin or duration of HCV
infection by sexual routes should consider multiplicity of
exposure in designing studies in various settings. For ex-
ample, blood contact from frequent sharing of razors
could also result in HCV transmission.
The recent United States National Health and Nutrition
Examination Surveys III (NHANES III), based on a ran-
dom probability cluster sample, found a high prevalence
of HCV among African-Americans. In contrast, our pa-
tients were recruited into an HCV study protocol after
satisfying enrollment criteria, and African-Americans
were under-represented relative to the Birmingham city
and Alabama state populations. Less than 10% of our
population was uninsured and this demographic proba-
bly more closely resembles those seen in offices of pri-
vate physicians than in other groups (such as a random
population sample). Because ongoing HCV awareness
campaigns will likely bring increasing numbers of HCV
patients to private physicians, those physicians should
be providing appropriate advice on disease management
(e.g., curtailing alcohol consumption and consideration
of antiviral therapy). They may advise patients on pre-
venting spread of the virus, but also prevent excessive
anxiety in this respect. Under most circumstances trans-
mission rates are low, but all potential sources of trans-
mission should be discussed.
Currently in the United States for most physicians in pri-
vate practice, HCV patients frequently first present with
abnormal alanine amino transferase (ALT) levels or are
found to be HCV positive as part of a routine health
check for life insurance or attempt to donate blood. With
the increased HCV awareness campaigns, however, it is
plausible that an increasing number of patients seen in
physician offices are there because they have a history of
injection drug use or have received at sometime in the
past blood or blood products and consequently over-rep-
resent the number of individuals with known risk fac-
tors. It is also possible that due to the exclusion criteria
of our study (none were HIV or HBV positive) those with
"high risk" sexual behaviors were excluded from this
study. Addressing these issues was out of the scope of the
present case series; however they should be addressed in
future protocols examining HCV transmission in specific
"high-risk" groups such as those with a high prevalence
of HIV disease, or those who had HCV diagnosed in clin-
ics for the treatment of sexually transmitted diseases. A
case-control comparison of tertiary care and primary
Table 1B: B. Number and % of the 148 patients exposed to suc-
cessively higher numbers of different risk factors simultaneously 
(frequency of multiple risk factors).
NO. RISK FACTORS NO. PATIENTS (%)
No known risk factor 7 (4.7)
1 23 (15.5)
2 41 (27.7)
3 38 (25.7)
4 21 (14.2)
5 13 (8.8)
6 5 (3.4)
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care clinic populations would help clarify some of these
issues.
Although blood transfusion was recently reported to ac-
count for only 7% of HCV infections in the US [1], 40% of
our patients received transfusions. Many of these pa-
tients were identified in HCV-screening campaigns that
focused on recipients of transfusions before 1992, prior
to the introduction of more sensitive HCV testing. In our
population the older age of recipients of blood products
compared with IDUs likely reflects a cohort effect due to
the relatively higher risk of acquiring HCV from blood
transfusion in the more distant past.
Sexual activity was not implicated as an independent risk
factor even after exclusion of individuals exposed to
blood or injection drugs. Other studies, including those
among spouses, have suggested low sexual transmission
of HCV [13,14,15]. Frequent sharing of razors and tooth-
brushes among persons who reported sexual exposure
also belies the automatic assumption of sexual transmis-
sion between a dually infected couple. The assessment of
risk remains particularly difficult when comparing infre-
quent but high-risk contact (e.g. parenteral exposure)
with more frequent but lower risk exposure such as sex-
ual activity. Even with our relatively general definition of
sexual exposure, we were unable to observe any individ-
uals with sexual contact as a sole risk factor. Inability to
test all current and/or past sexual partners of individuals
reporting sexual exposure precluded definitive confir-
mation of partner HCV status. We were therefore unable
to separate those who had at least one reported sexual
contact with a person suspected of having HCV from
those who had at least one sexual contact with a person
known to have HCV. Factors like piercing and tattooing
may need to be refined into different levels of risk de-
pending upon the setting (e.g. service by an unskilled in-
dividual versus a professional trained in proper hygiene).
The multiplicity of risk factors observed in our case se-
ries presents some important ramifications with respect
to disease surveillance. Many of the disease surveillance
networks employ a hierarchical algorithm to determine
routes for HCV acquisition when multiple risk factors are
present in individuals. While these hierarchies are based
on the presumed likelihood of transmission per expo-
sure, their use may potentially obscure the true contribu-
tion of "lower risk" exposures. Clearly, alternative
methods of modeling risk factors should also be consid-
ered. Most importantly, attributing HCV acquisition to
"lower risk" behaviors such as sexual exposure should be
done with caution, and only after exclusion of other risk
factors, and in particular, those of "higher risk," such as
parenteral contact. Detailed inquiry into risk factor ex-
posure may also increase accuracy in the ascertainment
of the time of HCV acquisition. Accurate estimates of the
duration of infection have proved useful in interpreting
data on factors that influence rate of disease progression
[16]. If a high number of individuals have multiple risk
factors, this may provide an inappropriate picture of the
true distributions of risk factors and consequently,
routes of acquisition.
In summary, identification of multiple risk factors for
HCV infection may be valuable for both individual pa-
tient assessment and population studies. The presence of
multiple risk factors within individuals should also
prompt us to re-evaluate how we interpret and present
surveillance data.
Table 2: Number and % of 148 patients with risk factors for HCV infection at two Alabama tertiary care medical centers, stratified by 
age, gender and race.
RISK FACTOR BY AGE BY GENDER BY RACE
≤ 45 >45 Male Female White Black
N (%) N (%) N (%) N (%) N(%) N (%)
N = 88 N = 60 N = 88 N = 60 N = 130 N = 18
Blood/Blood Prod 29 (33.0) 32 (53.3) 22 (25) 40 (66.7) 54 (41.5) 7 (38.9)
Drug Use 52 (59.0) 19 (31.7) 57 (64.8) 14 (23.3) 60 (46.2) 11 (61.1)
Body/Ear Piercing 45 (51.1) 28 (46.7) 18 (20.5) 55 (91.7) 61 (46.9) 11 (61.1)
Occupational 31 (35.2) 16 (26.7) 26 (29.5) 21 (35.0) 37 (28.5) 10 (55.6)
Tattooing 18 (20.5) 7 (11.7) 18 (20.5) 7 (11.7) 24 (18.5) 1 (5.6)
Sexual Exposure 42 (47.7) 13 (21.7) 62 (70.5) 23 (38.3) 50 (38.5) 5 (27.7)
Sharing of razors/ 42 (47.7) 23 (38.3) 36 (40.9) 29 (48.3) 56 (43.1) 9 (50)
toothbrushes
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